Lillian Brown, MD, PhD

Assistant Adjunct Professor

HIV, Infectious Disease, and Global Medicine

My research focuses on improving clinical outcomes among HIV-infected youth in sub-Saharan Africa and to study social network-informed approaches to support engagement in HIV care and improve HIV treatment outcomes.

2019 - Diversity, Equity, and Inclusion Champion Training, University of California
Residency, 2014 - Medicine, University of California San Francisco
Internship, 2013 - Medicine, University of California San Francisco
M.D., 2012 - School of Medicine, University of North Carolina
PhD, 2010 - School of Public Health, Epidemiology, University of North Carolina
BA, 2001 - Biology, Harvard University
Fellowship, - Infectious Diseases, University of California San Francisco
Honors and Awards
  • Teri Liegler Young Scientist Career Award, UCSF, 2019
  • Center for AIDS Research Excellence in Behavioral Research, UCSF, 2018
  1. Management and Outcomes of Critically-Ill Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series.
  2. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
  3. The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda.
  4. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study.
  5. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya.
  6. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya.
  7. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis.
  8. A patient-centered multi-component strategy for accelerated linkage to care following community-wide HIV testing in rural Uganda and Kenya.
  9. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study.
  10. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat.
  11. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya.
  12. High levels of retention in care with streamlined care and universal test and treat in East Africa.
  13. Antimicrobial Resistance: A Call to Action!
  14. Maximizing HIV partner notification opportunities for index patients and their sexual partners in Malawi.
  15. The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia.
  16. Cost-effectiveness of provider-based HIV partner notification in urban Malawi.
  17. Point-of-Care Diagnostics for Acute HIV Infection: An Important Public Health Priority.
  18. Predicting partner HIV testing and counseling following a partner notification intervention.
  19. Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
  20. HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention.
  21. Viewpoint: Gentamicin for treatment of gonococcal urethritis in Malawi.
  22. Accelerating worldwide syphilis screening through rapid testing: a systematic review.
  23. Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
  24. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007.
  25. Epidemiology of injuries at a tertiary care center in Malawi.
  26. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
  27. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania.
  28. Genetic and environmental influences on bone mineral density in pre- and post-menopausal women.
  29. Assessment of sex-specific genetic and environmental effects on bone mineral density.